ArticleComputational and structural biotechnology journal2025
Internal validation strategy for high dimensional prognosis model: A simulation study and application to transcriptomic in head and neck tumors.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03017573 (Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Predictive Value of Machine Learning for Poststroke Mortality Risk: Systematic Review and Meta-Analysis.Journal of medical Internet research · 2026Pooled it
- Trial
- A combined radiomics-clinical nomogram for assessing MRI-defined femoral Head collapse status in osteonecrosis of the femoral Head.Journal of applied clinical medical physics · 2026Article
- Immuno-metabolic biomarkers for 90-day prognostication after acute ischemic stroke: a classically solved QUBO-COPE modeling and biological contextualization study.Journal of translational medicine · 2026Article
- Multi-omics data integration using time-to event endpoint and supervised Cox penalized regression: a comprehensive review.Clinical and experimental medicine · 2026Review
- A Cytokine-Related Gene Signature for Pan-Cancer Prognostic Stratification and Malignant Phenotype Characterization.International journal of molecular sciences · 2026Article
- Exposome influences: a multi-omics perspective on the combined toxic effects of pharmaceuticals and personal care products in Alzheimer's disease.Frontiers in toxicology · 2026Review
- An Interpretable Omics-to-Image Transformer Framework for Cancer Prognosis Prediction.Computational and structural biotechnology journal · 2026Article
- A clustering-stratified cross-validation framework for validating omics survival models: application to head and neck cancer.BMC medical research methodology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Predictive models using high-dimensional data, such as genomics and transcriptomics, are increasingly used in oncology for time-to-event endpoints. Internal validation of these models is crucial to mitigate optimism bias prior to external validation. Common strategies include train-test, bootstrap, and (nested) cross-validation. However, no benchmark exists for these methods in high-dimensional settings. We aimed to compare these strategies and provide recommendations in the field of transcriptomic analysis. Method: A simulation study was conducted using data from the SCANDARE head and neck cohort (NCT03017573) including n = 76 patients. Simulated datasets included clinical variables (age, sex, HPV status, TNM staging), transcriptomic data (15,000 transcripts), and disease-free survival, with a realistic cumulative baseline hazard. Sample sizes of 50, 75, 100, 500, and 1000 were simulated, with 100 replicates each. Cox penalized regression was performed for model selection, followed by train-test 70 % training), bootstrap (100 iterations), 5-fold cross-validation, and nested cross-validation (5 ×5) to assess discriminative (time-dependent AUC and C-Index) and calibration (3-year integrated Brier Score) performance. Results: Train-test validation showed unstable performance. Conventional bootstrap was over-optimistic, while the 0.632 + bootstrap was overly pessimistic, particularly with small samples (n = 50 to n = 100). The k-fold cross-validation and nested cross-validation improved performance with larger sample sizes, with k-fold cross-validation demonstrating greater stability. Nested cross-validation showed performance fluctuations depending on the regularization method for model development. Conclusion: The K-fold cross-validation and nested cross-validation are recommended for internal validation of Cox penalized models in high-dimensional time-to-event settings. These methods offer greater stability and reliability compared to train-test or bootstrap approaches, particularly when sample sizes are sufficient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.